Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.
Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger H, Essers L, Weber B, Hermann K, Rosenthal A, Hartmann A, Dahl E.
Klopocki E, et al. Among authors: klaman i.
Int J Oncol. 2004 Sep;25(3):641-9.
Int J Oncol. 2004.
PMID: 15289865